Study: Patient’s Genetic Characteristics May Help Differentiate HER2-Low Advanced Breast Cancers and Guide Treatment Selection
In a new study led by Yale Cancer Center researchers at Yale School of Medicine, their findings revealed important differences in the genetic makeup of HER2-low advanced breast cancers — a discovery that could lead to better treatment options for patients.
Study: New Biomarker Tool Helps Select Targeted Therapies to Treat Metastatic Breast Cancers
A team of researchers led by senior author Dr. David Rimm and first author Charles “Jack” Robbins at Yale Cancer Center evaluated a new “selective” biomarker called Troplex™, which assesses HER2, TROP2, and cytokeratin using quantitative immunofluorescence.
Overdiagnosis and Preventative Screening: A Q&A With Ilana Richman
In a Q&A, Ilana Richman, MD, MHS, assistant professor of medicine (general medicine), discusses why overdiagnosis is a concern, the challenges of assessing the benefit of new screening technologies, and the risks and benefits people should weigh when considering preventative screening.
5 Things You Need to Know About Breast Cancer Right Now
Every 14 seconds, a woman somewhere in the world is diagnosed with breast cancer. It’s the most common cancer worldwide, with an estimated 2.3 million new cases each year. And rates have been slowly increasing over the past two decades. The good news is that death rates are dramatically decreasing—there’s been a 43 percent decline since 1989. This is in large part due to improvements in both detection and treatments, says Eric Winer, MD, director of Yale Cancer Center and president and physician-in-chief of Smilow Cancer Hospital.Source: Oprah Daily
CT Breast Cancer Survivor Helps Single Mothers with Disease Pay for Housing
Roberta Lombardi shares how the organization she founded after her own bout with early breast cancer in 2016. Infinite Strength, now in its fifth year, provides six months of housing funding up to $6,000 per year for single mothers with metastatic breast cancer. So far in 2023 alone, the organization, which the 56-year-old Lombardi runs from her home without a salary, has given out more than $300,000 in grants to single mothers with stage 4 breast cancer whose incomes are 200 percent below the poverty line. Lombardi believes it's the only organization of its kind nationally that supports under-served single mothers facing stage 4 cancer with six months of rent or mortgage money and extras such as food cards, day retreats, a holiday tea and a caring ear to help women keep their family together during a difficult time.Source: CT Insider
Yale Cancer Center Researchers Awarded 2023-2024 Grants from the Breast Cancer Research Foundation
The Breast Cancer Research Foundation (BCRF) Scientific Advisory Board and its Board of Directors recently announced its $60.2 million commitment to fund breast cancer research in 2023-2024, supporting more than 250 scientists at leading academic and medical institutions, including eight grants at Yale Cancer Center and Smilow Cancer Hospital.